Pharma Stocks

Mizuho Strategist: Healthcare Is Now a Value Sector as Pharma Stocks Underperform Tech

© ipopba / iStock via Getty Images After years of lagging the market, healthcare may be taking on a new…

Read More »

Healthcare Is Now a Value Sector as Pharma Stocks Underperform Tech

Quick Read Merck’s Keytruda posted $8 billion in Q1 sales, while Summit’s ivonescimab faces binary risk ahead of its November…

Read More »

A Ligand Pharmaceuticals (LGND) Insider Sold 5,000 Shares for $1.1 Million

Andrew Reardon, CLO & Secretary at Ligand (LGND +0.46%), reported the sale of 5,000 shares of Common Stock for approximately…

Read More »

Are Daiichi Sankyo Company’s (TSE:4568) ASCO 2026 ADC Data Deepening Its Oncology Moat?

In late May 2026, Daiichi Sankyo announced it would present more than 25 oncology abstracts at the ASCO 2026 meeting,…

Read More »

Is Ligand Pharmaceuticals (LGND) Still Undervalued After Its Strong Recent Share Price Momentum

Recent performance context for Ligand Pharmaceuticals (LGND) Without a specific news event driving headlines today, Ligand Pharmaceuticals (LGND) still gives…

Read More »

Assessing Sumitomo Pharma (TSE:4506) Valuation After Recent Share Price Volatility

Setting the scene for Sumitomo Pharma’s recent share performance Sumitomo Pharma (TSE:4506) has seen its share price move in different…

Read More »

Zealand Pharma (CPSE:ZEAL) Valuation Revisited After New Petrelintide Phase 2 Obesity Data And Phase 3 Plans

Zealand Pharma (CPSE:ZEAL) is back in focus after presenting new Phase 2 ZUPREME-1 data at the American Diabetes Association 2026…

Read More »

A Look At Amneal Pharmaceuticals (AMRX) Valuation After Romidepsin Approval And Positive CREXONT Trial Data

Amneal Pharmaceuticals (AMRX) stock moved after investors reacted to two fresh updates: FDA approval of its romidepsin injection with Competitive…

Read More »

A Look At Takeda Pharmaceutical (TSE:4502) Valuation As New CEO And Transformation Plan Take Shape

Takeda Pharmaceutical (TSE:4502) is in the spotlight after appointing Julie Kim as CEO and outlining a transformation plan focused on…

Read More »

‘Pharma Bro’ Says ‘GLPs Are Doing Fine’ After Similar Fears

Shares of ABVX closed down 44% on Tuesday, clocking its worst day ever, on reports of a number of non-melanoma…

Read More »